Global Home Healthcare Market 2016-2020

Price :
Published : May-2016
No. of Pages : 66

Home healthcare refers to a wide range of medical products (include heart rate monitors, blood glucose level indicators, and nebulizers), services, and solutions that provide health monitoring, treatment, and physical support to patients or customers at home. People do not need to visit a hospital or any other healthcare facility to benefit from these offerings; they can be accessed in the comfort of homes. The home healthcare market offers complete solutions that include the product as well as software and support from consultants and physicians.

The analysts forecast Global Home Healthcare Market to grow at a CAGR of 8.85% during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the Global Home Healthcare Market for 2016-2020.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • Europe
  • MEA

The report, Global Home Healthcare Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Johnson & Johnson
  • Omron Healthcare
  • Philips
  • McKesson
  • Roche Holdings

Other prominent vendors

  • A&D Company
  • Abbott
  • Almost Family
  • Apria Healthcare
  • eCaring
  • Fresenius
  • Gentiva Health Services
  • Interim Healthcare
  • Kindred Healthcare
  • Linde Healthcare
  • LJC Group
  • Kinnser Software
  • Rotech Healthcare

Market driver

  • Growing demand for affordable healthcare solutions
  • For a full, detailed list, view our report

Market challenge

  • Complexity in pricing
  • For a full, detailed list, view our report

Market trend

  • Integration of mobile devices with home healthcare systems
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : Technavio
More Reports
Title Price Buy Now

Helix BioPharma Corp (HBP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Helix BioPharma Corp (Helix) is a biopharmaceutical company with a focus in the field of cancer therapy. The company develops drug candidates for the prevention and treatment of cancer. It develops drugs based on its proprietary technologies. DOS47, the company's proprietary broad anti-cancer therapeutic platform has yielded two new drug product candidates, V-DOS47 and L-DOS47. V-DOS47 uses the company's proprietary DOS47 technology conjugated to VEGFR target wide range of cancers and L-DOS47 is designed to treat inoperable, locally advanced, recurrent or metastatic non-small cell lung cancer (NSCLC). It also continues to actively pursue additional novel antibody based technologies for cell-based therapies. Helix is headquartered in Aurora, Ontario, Canada. Helix BioPharma Corp (......

UCB SA (UCB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines include Cimzia for ankylosing spondylitis, axial spondylarthritis, Crohn's disease, psoriatic arthritis and rheumatoid arthritis; Neupro for Parkinson's disease and restless legs syndrome; and Vimpat, Keppra and Briviact for epilepsy. UCB is also developing new therapies for neurological and immunological diseases. The company operates subsidiaries in the US, Japan, China, Germany, Italy, Spain, France, the UK, Ireland, Belgium, Brazil, Russia, India, Mexico, Turkey and other countries. UCB is......

GeoVax Labs Inc (GOVX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary GeoVax Labs Inc (GeoVax) is a clinical-stage biotechnology company, which develops human vaccines for diseases caused by HIV, cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company's vaccine development programs focus on human immunodeficiency virus (HIV), Zika virus and hemorrhagic fever viruses (Ebola, Marburg, Lassa fever) and for cancer immunotherapy. Its advanced vaccines under development act against the clade B subtype of the HIV virus and clade C subtype. The company developed its proprietary vaccine technology in collaboration with the U.S. National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC) and Emory University. GeoVax is headquartered in Smyrna, Georgia, the US. G......

ICON Plc (ICLR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The company's service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization and outcomes, consulting, functional services provision, medical imaging, laboratory services, resourcing solutions and strategic support and tactical solutions for traditional, in vitro diagnostic, and software devices. The company offers research services in areas such as cancer, genomics, central nervous system, cardiovascular, endocrine and metabolic disorders, gastrointestinal, medical......

Adventist Health System – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Adventist Health System (AHS) is a faith based medical health care organization. It serves through hospitals, nursing facilities and home care agencies. The organization, through its technologies and clinical research provide general medical care and specialized care for more than four million patients every year. AHS provides various healthcare services such as cardiology center, diabetes, behavioral health, orthopedics, wound care, women's services, neurosurgery, eye care center, family practice, geriatrics care, pain medicine, pediatrics, psychology radiology center, rehab and many others. It also includes urgent care centers, home health and hospice agencies, and skilled nursing facilities. AHS is headquartered in Winter Park, Florida, the US. Adventist Health System - Pharma......

AstraZeneca Plc (AZN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and neurological diseases. The company's product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies and through distributors and local representative offices. The company markets its products to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa and Australasia. AstraZeneca is headquartered in Cambridge, the UK. AstraZeneca Plc (AZN) - Pharmaceutica......

Oragenics Inc (OGEN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Oragenics Inc (Oragenics) is a biopharmaceutical company that focuses on the development and commercialization of novel antibiotics against infectious disease and develops treatments for oral mucositis. The company develops a new class of potent gram-positive antibiotics which are called Lantibiotics for combating resistant bacterial infections. Its pipeline products include MU1140, being tested for healthcare associated infections caused by drug-resistant bacteria. The company develops other candidates and technologies in the oral care and weight loss areas which include AG013 for the treatment of oral mucositis in cancer patients; OG716 in preclinical phase for healthcare-associated infections; and LPT3-04 for weight loss. Oragenics is headquartered in Tampa, Florida, the US. O......

Laboratoires Pierre Fabre SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation develops products and solutions ranging from health to beauty. Its product portfolio comprises wide range of complementary products, from prescribed drugs to dermo-cosmetics, including over-the-counter drugs and natural health products. The company's products address the full spectrum of health care needs from pathologies such as cancer or atopical dermatitis to rare diseases including pediatric hemangioma, family hygiene to skin, hair and scalp care; and from day-to-day illnesses. Pierre Fabre sells and markets its products under various brands which include Derma, Galenic Klorane, Avene, Ducray, Rene Furterer, and others. Pierre Fabre is headquartered in Ile-de-France, France. Laboratoires Pier......

Seattle Genetics Inc (SGEN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Seattle Genetics Inc (Seattle Genetics) is a biotechnology company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer. The company's lead product Adcetris (brentuximab vedotin) is an antibody-drug conjugate indicated for the treatment of relapsed Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (sALCL). Seattle Genetics' product pipeline consists of SGN-CD33A (vadastuximab talirine) for acute myeloid leukemia (AML) and myelodysplastic syndrome; and ASG-22ME (enfortumab vedotin) for metastatic urothelial cancer. Its pipeline also comprises six antibody-drug conjugate (ADC) programs and two immuno-oncology programs in various clinical stages of development. It uses ADC and sugar-engineered antibody (SEA) technologies for......

Infinity Pharmaceuticals Inc (INFI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company, which discovers and develops medicines to people suffering with difficult-to-treat diseases. It focuses on small molecule drugs designed to address diseases in the areas of cancer and inflammation. The company's product pipeline comprises lead product candidate, duvelisib, also known as IPI-145 is an oral, dual-inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K) in Phase 3. The product is being evaluated in various product development stages for the treatment of indolent non-Hodgkin lymphoma (iNHL), chronic lymphocytic leukemia (CLL) and advanced hematologic malignancies. Infinity Pharmaceuticals is headquartered in Cambridge, Massachusetts, the US. Infinity Pharmaceu......